AUTOLOGOUS CONDITIONED PLASMA
Osteoarthritis of the Knee
QC Kinetix LLCother_biologicalPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Osteoarthritis of the Knee cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
tlc599 Taiwan Liposome Company | Phase 3 | BB |
Duloxetine Eli Lilly and Company | Phase 3 | BB |
Buprenorphine Purdue Pharma LP | Phase 3 | B |
DEXAMETHASONE Taiwan Liposome Company | Phase 3 | B |
Cntx-4975 Centrexion Therapeutics | Phase 2 | B |
View all 9 →
Same molecule, other indications
AUTOLOGOUS CONDITIONED PLASMA is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →